Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Mitoxantrone plus hydrocortisone beneficial in prostate cancer

    • 7 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Mitoxantrone plus hydrocortisone beneficial in prostate cancer. Pharmacoecon. Outcomes News 230, 10 (1999). https://doi.org/10.1007/BF03275110

    Download citation

    Keywords

    • Prostate Cancer
    • Hydrocortisone
    • Mitoxantrone
    • Monotherapy Group
    • Receive Combination Therapy